Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 48.64
-0.33 (-0.67%)
At close: Mar 9, 2026
Shanghai OPM Biosciences Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 6,325 | 5,577 | 4,148 | 6,332 | 8,460 | - | Upgrade
|
| Market Cap Growth | 33.81% | 34.44% | -34.49% | -25.16% | - | - | Upgrade
|
| Enterprise Value | 5,010 | 4,263 | 2,834 | 4,889 | 6,795 | - | Upgrade
|
| Last Close Price | 48.64 | 49.00 | 36.14 | 53.89 | 71.16 | - | Upgrade
|
| PE Ratio | 131.46 | 133.75 | 197.05 | 117.18 | 80.29 | - | Upgrade
|
| Forward PE | 50.14 | 55.21 | 40.23 | - | - | - | Upgrade
|
| PS Ratio | 17.82 | 15.71 | 13.96 | 26.04 | 28.74 | - | Upgrade
|
| PB Ratio | 3.01 | 2.66 | 1.98 | 2.93 | 3.87 | - | Upgrade
|
| P/TBV Ratio | 3.06 | 2.70 | 2.02 | 2.99 | 3.95 | - | Upgrade
|
| P/OCF Ratio | - | - | 59.91 | 109.26 | 75.80 | - | Upgrade
|
| EV/Sales Ratio | 14.12 | 12.01 | 9.53 | 20.11 | 23.08 | - | Upgrade
|
| EV/EBITDA Ratio | 58.69 | 49.94 | 67.11 | 103.93 | 59.98 | - | Upgrade
|
| EV/EBIT Ratio | 101.01 | 85.94 | 438.58 | 256.99 | 76.35 | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 0.69 | 0.69 | 1.25 | 1.24 | 0.75 | 1.45 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 14.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.62 | -0.62 | -0.61 | -0.65 | -0.74 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -15.38 | -15.38 | -30.08 | -30.06 | -14.34 | -3.08 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 24.61 | 72.18 | 45.98 | -26.48 | Upgrade
|
| Asset Turnover | - | - | 0.13 | 0.11 | 0.19 | 0.33 | Upgrade
|
| Inventory Turnover | - | - | 2.63 | 2.18 | 2.76 | 3.72 | Upgrade
|
| Quick Ratio | - | - | 12.18 | 22.37 | 20.18 | 4.09 | Upgrade
|
| Current Ratio | - | - | 12.97 | 23.49 | 20.94 | 4.60 | Upgrade
|
| Return on Equity (ROE) | 1.99% | 1.99% | 0.95% | 2.45% | 7.67% | 11.43% | Upgrade
|
| Return on Assets (ROA) | - | - | 0.18% | 0.51% | 3.60% | 5.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.32% | 5.20% | 0.46% | 2.52% | 17.58% | 17.84% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 0.30% | 0.90% | 3.90% | 8.50% | Upgrade
|
| Earnings Yield | 0.66% | 0.75% | 0.51% | 0.85% | 1.24% | - | Upgrade
|
| FCF Yield | - | - | -1.24% | -0.31% | -0.42% | - | Upgrade
|
| Dividend Yield | 0.86% | - | 1.16% | 0.82% | 0.60% | - | Upgrade
|
| Payout Ratio | - | - | 243.29% | 136.63% | 1.97% | 2.99% | Upgrade
|
| Buyback Yield / Dilution | 3.64% | 3.64% | -1.72% | -13.48% | -17.43% | -0.20% | Upgrade
|
| Total Shareholder Return | 4.50% | 3.64% | -0.56% | -12.66% | -16.83% | -0.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.